Logo image of PETQ

PETIQ INC (PETQ) Stock Fundamental Analysis

USA - NASDAQ:PETQ - US71639T1060 - Common Stock

30.98 USD
-0.01 (-0.03%)
Last: 10/24/2024, 8:00:01 PM
30.98 USD
0 (0%)
After Hours: 10/24/2024, 8:00:01 PM
Fundamental Rating

5

Taking everything into account, PETQ scores 5 out of 10 in our fundamental rating. PETQ was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of PETQ get a neutral evaluation. Nothing too spectacular is happening here. PETQ is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

PETQ had positive earnings in the past year.
In the past year PETQ had a positive cash flow from operations.
PETQ had negative earnings in 4 of the past 5 years.
Of the past 5 years PETQ 4 years had a positive operating cash flow.
PETQ Yearly Net Income VS EBIT VS OCF VS FCFPETQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

PETQ has a Return On Assets of 1.48%. This is in the better half of the industry: PETQ outperforms 61.74% of its industry peers.
PETQ has a Return On Equity of 5.13%. This is in the better half of the industry: PETQ outperforms 67.83% of its industry peers.
PETQ's Return On Invested Capital of 7.96% is amongst the best of the industry. PETQ outperforms 80.87% of its industry peers.
PETQ had an Average Return On Invested Capital over the past 3 years of 4.51%. This is below the industry average of 9.33%.
The last Return On Invested Capital (7.96%) for PETQ is above the 3 year average (4.51%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.48%
ROE 5.13%
ROIC 7.96%
ROA(3y)-2.53%
ROA(5y)-4%
ROE(3y)-9.44%
ROE(5y)-13.98%
ROIC(3y)4.51%
ROIC(5y)N/A
PETQ Yearly ROA, ROE, ROICPETQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20 -30

1.3 Margins

With a decent Profit Margin value of 1.17%, PETQ is doing good in the industry, outperforming 64.35% of the companies in the same industry.
PETQ has a Operating Margin of 6.32%. This is in the better half of the industry: PETQ outperforms 70.43% of its industry peers.
PETQ's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 24.63%, PETQ perfoms like the industry average, outperforming 52.17% of the companies in the same industry.
In the last couple of years the Gross Margin of PETQ has grown nicely.
Industry RankSector Rank
OM 6.32%
PM (TTM) 1.17%
GM 24.63%
OM growth 3YN/A
OM growth 5Y28.63%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.79%
GM growth 5Y7.79%
PETQ Yearly Profit, Operating, Gross MarginsPETQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

5

2. Health

2.1 Basic Checks

PETQ has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for PETQ has been increased compared to 1 year ago.
The number of shares outstanding for PETQ has been increased compared to 5 years ago.
Compared to 1 year ago, PETQ has an improved debt to assets ratio.
PETQ Yearly Shares OutstandingPETQ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
PETQ Yearly Total Debt VS Total AssetsPETQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 2.60 indicates that PETQ is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.60, PETQ is in the better half of the industry, outperforming 66.09% of the companies in the same industry.
PETQ has a debt to FCF ratio of 36.99. This is a negative value and a sign of low solvency as PETQ would need 36.99 years to pay back of all of its debts.
PETQ has a Debt to FCF ratio (36.99) which is comparable to the rest of the industry.
A Debt/Equity ratio of 1.69 is on the high side and indicates that PETQ has dependencies on debt financing.
The Debt to Equity ratio of PETQ (1.69) is worse than 73.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.69
Debt/FCF 36.99
Altman-Z 2.6
ROIC/WACC1.05
WACC7.57%
PETQ Yearly LT Debt VS Equity VS FCFPETQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M 400M

2.3 Liquidity

PETQ has a Current Ratio of 2.58. This indicates that PETQ is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PETQ (2.58) is better than 82.61% of its industry peers.
PETQ has a Quick Ratio of 1.68. This is a normal value and indicates that PETQ is financially healthy and should not expect problems in meeting its short term obligations.
PETQ's Quick ratio of 1.68 is fine compared to the rest of the industry. PETQ outperforms 66.09% of its industry peers.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 1.68
PETQ Yearly Current Assets VS Current LiabilitesPETQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

6

3. Growth

3.1 Past

PETQ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.58%, which is quite impressive.
PETQ shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.07% yearly.
The Revenue has grown by 13.57% in the past year. This is quite good.
The Revenue has been growing by 15.83% on average over the past years. This is quite good.
EPS 1Y (TTM)64.58%
EPS 3Y20.01%
EPS 5Y7.07%
EPS Q2Q%52.17%
Revenue 1Y (TTM)13.57%
Revenue growth 3Y12.2%
Revenue growth 5Y15.83%
Sales Q2Q%4.58%

3.2 Future

The Earnings Per Share is expected to grow by 20.07% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 6.21% on average over the next years.
EPS Next Y34.03%
EPS Next 2Y25.33%
EPS Next 3Y23.23%
EPS Next 5Y20.07%
Revenue Next Year8.33%
Revenue Next 2Y6.86%
Revenue Next 3Y7.06%
Revenue Next 5Y6.21%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PETQ Yearly Revenue VS EstimatesPETQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
PETQ Yearly EPS VS EstimatesPETQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.61, the valuation of PETQ can be described as rather expensive.
73.04% of the companies in the same industry are more expensive than PETQ, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of PETQ to the average of the S&P500 Index (27.42), we can say PETQ is valued slightly cheaper.
A Price/Forward Earnings ratio of 16.30 indicates a correct valuation of PETQ.
Based on the Price/Forward Earnings ratio, PETQ is valued a bit cheaper than the industry average as 73.91% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.94. PETQ is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.61
Fwd PE 16.3
PETQ Price Earnings VS Forward Price EarningsPETQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PETQ indicates a somewhat cheap valuation: PETQ is cheaper than 73.04% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, PETQ is valued a bit cheaper than the industry average as 60.87% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 77.88
EV/EBITDA 11.52
PETQ Per share dataPETQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PETQ's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of PETQ may justify a higher PE ratio.
A more expensive valuation may be justified as PETQ's earnings are expected to grow with 23.23% in the coming years.
PEG (NY)0.58
PEG (5Y)2.77
EPS Next 2Y25.33%
EPS Next 3Y23.23%

0

5. Dividend

5.1 Amount

No dividends for PETQ!.
Industry RankSector Rank
Dividend Yield N/A

PETIQ INC

NASDAQ:PETQ (10/24/2024, 8:00:01 PM)

After market: 30.98 0 (0%)

30.98

-0.01 (-0.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-07 2024-08-07/bmo
Earnings (Next)11-07 2024-11-07/amc
Inst Owners99.11%
Inst Owner Change0%
Ins Owners0.82%
Ins Owner Change0%
Market Cap933.43M
Analysts76.36
Price Target31.11 (0.42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.83%
Min EPS beat(2)33.29%
Max EPS beat(2)38.36%
EPS beat(4)4
Avg EPS beat(4)596.09%
Min EPS beat(4)33.29%
Max EPS beat(4)2252.94%
EPS beat(8)7
Avg EPS beat(8)329.26%
EPS beat(12)9
Avg EPS beat(12)214.99%
EPS beat(16)11
Avg EPS beat(16)161.03%
Revenue beat(2)1
Avg Revenue beat(2)-0.84%
Min Revenue beat(2)-2.32%
Max Revenue beat(2)0.63%
Revenue beat(4)3
Avg Revenue beat(4)7.73%
Min Revenue beat(4)-2.32%
Max Revenue beat(4)18.56%
Revenue beat(8)6
Avg Revenue beat(8)5.08%
Revenue beat(12)9
Avg Revenue beat(12)4.61%
Revenue beat(16)11
Avg Revenue beat(16)4.38%
PT rev (1m)0%
PT rev (3m)5.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.9%
EPS NY rev (1m)0%
EPS NY rev (3m)8.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 19.61
Fwd PE 16.3
P/S 0.82
P/FCF 77.88
P/OCF 46.16
P/B 3.62
P/tB N/A
EV/EBITDA 11.52
EPS(TTM)1.58
EY5.1%
EPS(NY)1.9
Fwd EY6.13%
FCF(TTM)0.4
FCFY1.28%
OCF(TTM)0.67
OCFY2.17%
SpS37.65
BVpS8.56
TBVpS-3.09
PEG (NY)0.58
PEG (5Y)2.77
Profitability
Industry RankSector Rank
ROA 1.48%
ROE 5.13%
ROCE 10.07%
ROIC 7.96%
ROICexc 9.02%
ROICexgc 20.48%
OM 6.32%
PM (TTM) 1.17%
GM 24.63%
FCFM 1.06%
ROA(3y)-2.53%
ROA(5y)-4%
ROE(3y)-9.44%
ROE(5y)-13.98%
ROIC(3y)4.51%
ROIC(5y)N/A
ROICexc(3y)5.32%
ROICexc(5y)N/A
ROICexgc(3y)14.77%
ROICexgc(5y)N/A
ROCE(3y)5.71%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y40.46%
ROICexc growth 3YN/A
ROICexc growth 5Y36.64%
OM growth 3YN/A
OM growth 5Y28.63%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.79%
GM growth 5Y7.79%
F-Score8
Asset Turnover1.27
Health
Industry RankSector Rank
Debt/Equity 1.69
Debt/FCF 36.99
Debt/EBITDA 3.89
Cap/Depr 20.3%
Cap/Sales 0.73%
Interest Coverage 2.16
Cash Conversion 18.01%
Profit Quality 90.51%
Current Ratio 2.58
Quick Ratio 1.68
Altman-Z 2.6
F-Score8
WACC7.57%
ROIC/WACC1.05
Cap/Depr(3y)44.62%
Cap/Depr(5y)115.7%
Cap/Sales(3y)1.83%
Cap/Sales(5y)4.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.58%
EPS 3Y20.01%
EPS 5Y7.07%
EPS Q2Q%52.17%
EPS Next Y34.03%
EPS Next 2Y25.33%
EPS Next 3Y23.23%
EPS Next 5Y20.07%
Revenue 1Y (TTM)13.57%
Revenue growth 3Y12.2%
Revenue growth 5Y15.83%
Sales Q2Q%4.58%
Revenue Next Year8.33%
Revenue Next 2Y6.86%
Revenue Next 3Y7.06%
Revenue Next 5Y6.21%
EBIT growth 1Y62.93%
EBIT growth 3YN/A
EBIT growth 5Y48.99%
EBIT Next Year95.79%
EBIT Next 3Y33.01%
EBIT Next 5Y22.34%
FCF growth 1Y173.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y340.55%
OCF growth 3YN/A
OCF growth 5YN/A